Effects of omeprazole on intragastric pH and plasma gastrin are dependent on the CYP2C19 polymorphism
Authors:
Open Access
- 1 September 2000
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 119 (3) , 670-676
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- CYP2C19 Genotype and Phenotype Determined with Omeprazole in Patients with Acid-Related Disorders with and without Helicobacter pylori InfectionScandinavian Journal of Gastroenterology, 1998
- Pharmacokinetics, Metabolism and Interactions of Acid Pump InhibitorsClinical Pharmacokinetics, 1996
- Intragastric pH during Treatment with Omeprazole: Role ofHelicobacter pyloriandH. pylori-Associated GastritisScandinavian Journal of Gastroenterology, 1996
- Variability in individual response to various doses of omeprazoleDigestive Diseases and Sciences, 1994
- Polymorphic hydroxylation of S-mephenytoin and omeprazole metabolism in Caucasian and Chinese subjectsPharmacogenetics, 1992
- Gastric histology and plasma gastrin response to a meal in patients with duodenal ulcer disease after five years treatment with ranitidineAlimentary Pharmacology & Therapeutics, 1990
- Long-Term Omeprazole Treatment in Man: Effects on Gastric Endocrine Cell PopulationsDigestion, 1988
- Acid secretory capacity and plasma gastrin concentration after administration of omeprazole to normal subjectsAlimentary Pharmacology & Therapeutics, 1987
- The Effect of 20 Mg Omeprazole Daily on Serum Gastrin, 24-H Intragastric Acidity, and Bile Acid Concentration in Duodenal Ulcer PatientsScandinavian Journal of Gastroenterology, 1987
- Enterochromaffin-Like Cell Carcinoids of Gastric Mucosa in Rats after Life-Long Inhibition of Gastric SecretionDigestion, 1986